Avnet Beats Q3 on Record Sales, But Margin Dilution Lingers

What happened

Avnet reported fiscal Q3 2026 sales of $7.12B, up 34% year-over-year and ahead of estimates, driven by record Electronic Components sales and broad regional demand. While the topline surge signals a robust cycle turn, the DeepValue master report had flagged concerns about margin dilution from Asia-heavy mix and inventory days still above target at 86. The beat alone does not resolve the core thesis tension: whether volume growth will translate into operating leverage, especially given net debt/EBITDA of 4.3x and interest coverage of 2.1x. Investors should focus on whether operating margin improved sequentially and whether inventory days made progress toward the <80 target.

Implication

The Q3 beat validates the demand recovery narrative but does not yet confirm the operating leverage thesis. The master report's WAIT rating remains appropriate until the company demonstrates that higher volumes convert into operating margin expansion (target ~2.6%) and that inventory days fall below 80. The April 2026 note repayment and securitization renewal are key liquidity milestones. Until those metrics improve, the risk of margin compression and balance-sheet strain keeps the risk/reward unattractive at current valuation (~13.6x EV/EBITDA).

Thesis delta

The Q3 topline beat reinforces the bull case for volume growth but does not invalidate the bear case on margins. The thesis shifts from 'wait for cycle confirmation' to 'wait for profitability confirmation'—the demand is real, but the path to operating leverage remains uncertain.